Evidence map›Paper›PMID 41348722›Full record

ArticlePloS one2025

Radon exposure and COVID-19 mortality in pre-vaccination period: What links might exist?

Jean François Coudert, Ekaterina Dadachova, Gilles Maignant, Stephanie Jonathan

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jean François CoudertC&C IngeScience, Mouans-Sartoux, France.
Ekaterina DadachovaCollege of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada.
Gilles MaignantUniversité Côte d'Azur, RETINES (Risques, Epidémiologie, Territoires, Informations, Education et Santé), Nice, France.
Stephanie JonathanUniversité Côte d'Azur, RETINES (Risques, Epidémiologie, Territoires, Informations, Education et Santé), Nice, France.ORCID https://orcid.org/0000-0002-9857-7750

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radon, a naturally occurring radioactive gas known for its health risks, has recently gained attention for its potential protective role against COVID-19 mortality. This cross-sectional ecological study examined the relationship between indoor radon exposure and COVID-19 mortality rates across eight countries, including several European nations, the United States, and the State of Kerala, India, during the pre-vaccination period. The analyzed data on the subject were derived from recent scientific publications. The environmental aspect was represented by the variable "indoor radon concentration or probability of exceeding a radon concentration in indoor air," depending on data availability. Using national radon surveys and COVID-19 mortality statistics, statistical analyses, including Spearman's correlation and Kendall Tau, were conducted between March and December 2020. The findings revealed a consistent negative correlation between radon concentrations and COVID-19 mortality rates, indicating that higher radon concentrations were associated with lower mortality rates. Regions such as Finland and Sweden, where radon exposure was relatively high, experienced significantly lower mortality. With Sweden and Finland showing a mortality risk reduction factor of respectively 1,42 and 5,47 during the first wave compared to the UK where Radon levels are very low. Although the findings are not overwhelmingly strong, the data suggest that radon exposure may have a mitigating effect on COVID-19 mortality.

Indexed as

Air Pollution, IndoorCOVID-19RadonAir Pollutants, RadioactiveCross-Sectional StudiesEuropeHumansIndiaSARS-CoV-2VaccinationAir Pollutants, RadioactiveRadon

Identifiers

PMID41348722
PMCPMC12680143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.